Carregant...
Direct Imaging of Drug Distribution and Target Engagement of the PARP Inhibitor Rucaparib
Poly(ADP-ribose)polymerase (PARP) inhibitors have emerged as potent antitumor drugs. Here, we describe the intrinsic fluorescence properties of the clinically approved PARP inhibitor rucaparib and its potential to directly measure drug distribution and target engagement—a critical factor for underst...
Guardat en:
| Publicat a: | J Nucl Med |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Society of Nuclear Medicine
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6071506/ https://ncbi.nlm.nih.gov/pubmed/29572258 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.117.205765 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|